MedTrace Logo

The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy

NCT01041183 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2009-12-31

No results posted yet for this study

Summary

Patients undergoing general anesthesia for laparoscopic cholecystectomy have a high risk of postoperative nausea and vomiting (PONV). The investigators investigated the effect of oral and IV ramosetron on PONV prophylaxis after laparoscopic cholecystectomy.

Conditions

Interventions

DRUG

intravenous ramosetron

0.3 mg IV ramosetron (group I)

DRUG

oral ramosetron

0.1 mg oral ramosetron (group II)

DRUG

oral and IV ramosetron

0.1 mg oral ramosetron plus 0.3 mg IV ramosetron (group III).

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2009-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01041183 on ClinicalTrials.gov